Aniling completes the Retos Colaboración project with the development of a genetic and epigenetic test (GEUS-LB®) for the early detection of colorectal cancer in a blood sample. The Aniling -led project uses patented GEUS …
Miguel A. Peinado, CSO at Aniling, is Co-Director of CARE, the new Translational Program in Cancer Research promoted by the IGTP, which was presented last month in the Hospital Universitari Germans Trias …
This week Aniling is attending the ERIC | European Research Initiative on CLL International Meeting in Barcelona focused on Chronic Lymphocytic Leukemia (CLL) as a paradigmatic disease for realizing the concepts of precision medicine towards improving …
The health biotechnology magazine Farmabiotec reports on Aniling’s late achivements. Farmabiotec goes through Aniling’s IVD tests for chronic lymphocytic leukaemia, colorectal cancer and liquid biopsy and highlights their recent CE …
Every 1 September, the global CLL community unites to raise awareness about chronic lymphocytic leukemia (CLL) and give those affected by a diagnosis of CLL a much needed voice. On …
Aniling has obtained CE certification for its first in vitro diagnostic (IVD) tests for chronic lymphocytic leukaemia, colorectal cancer and liquid biopsy. Aniling has successfully complied with the requirements established …
Expansión newspaper explains the company’s latest milestone: Aniling obtains CE marking for three in vitro tests for chronic lymphocytic leukaemia, colorectal cancer and liquid biopsy. News written by Gabriel Trindade …
Last week, Aniling participated in the BBQ2022 organized by CataloniaBio & HealthTech. After the obliged pause due to the COVID-19 pandemic, the BBQ welcomed nearly 400 professionals looking to meet …
Aniling is looking for a motivated QA/RA Manager to maintain and improve our company-wide quality management system that complies with the requirements of ISO 13485 and the regulation under which …
Over the last few weeks, Aniling has had the opportunity to take part in the amazing IVD Programme organized by CataloniaBio & HealthTech, designed to boost projects from the IVD companies. Thank you to …
